Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

May 29, 2013

Primary Completion Date

November 1, 2014

Study Completion Date

June 15, 2018

Conditions
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage II Pancreatic CancerStage III Pancreatic Cancer
Interventions
DRUG

oxaliplatin

IV

DRUG

irinotecan

IV

DRUG

leucovorin

IV

DRUG

5-fluorouracil

IV

DRUG

capecitabine

PO

RADIATION

radiation

PROCEDURE

surgery

DRUG

gemcitabine

IV

Trial Locations (14)

19111

Fox Chase Cancer Center, Philadelphia

21287

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore

27157

Wake Forest University Health Sciences, Winston-Salem

40202

The James Graham Brown Cancer Center at University of Louisville, Louisville

43210

Ohio State University Comprehensive Cancer Center, Columbus

45069

University Pointe, West Chester

45267

University of Cincinnati, Cincinnati

53792

University of Wisconsin Hospital and Clinics, Madison

55905

Mayo Clinic, Rochester

60201

NorthShore University HealthSystem-Evanston Hospital, Evanston

60637

University of Chicago Comprehensive Cancer Center, Chicago

70121

Ochsner Medical Center Jefferson, New Orleans

77030

M D Anderson Cancer Center, Houston

92093

UC San Diego Moores Cancer Center, La Jolla

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT01821612 - Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer | Biotech Hunter | Biotech Hunter